Elan Corp. plc's financial struggles and subsequent restructuring will have a widespread impact on the North American biotechnology industry, already operating in a depressed market, and a number of the 55 joint ventures biotech companies have with the Dublin, Ireland-based firm. (BioWorld Today) Read More
